SPONSOR
Erkan Gol
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Leiomyoma (Uterine Fibroids)Adenomyoma of UterusUterine BleedingPelvic Organ Prolapse (POP)Postoperative Pain
Erkan Gol is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Leiomyoma (Uterine Fibroids), Adenomyoma of Uterus, Uterine Bleeding, Pelvic Organ Prolapse (POP).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Erkan Gol
How many clinical trials has Erkan Gol sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Erkan Gol, of which 2 are actively recruiting participants. These trials cover conditions including Leiomyoma (Uterine Fibroids), Adenomyoma of Uterus, Uterine Bleeding. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Erkan Gol research focus on?
Erkan Gol clinical trials span Leiomyoma (Uterine Fibroids), Adenomyoma of Uterus, Uterine Bleeding, Pelvic Organ Prolapse (POP), Postoperative Pain. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Erkan Gol clinical trial?
To participate in a Erkan Gol trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Erkan Gol trials with current recruitment status updated daily.
Clinical Trials by Erkan Gol
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology